HLA-B*2709 and lack of susceptibility to sacroiliitis: Further support from the clinic

Clinical and Experimental Rheumatology

Volumn 26, Issue 6, 2008, Pages 1111-1112

  Cauli, Alberto ^a   Vacca, Alessandra ^a   Dessole, Grazia ^a   Fiorillo, Maria Teresa ^b   Porru, Giovanni ^a   Ibba, Valentina ^a   Mura, Valentina ^a   Piga, Matteo ^a   Sorrentino, Rosa ^b   Mathieu, Alessandro ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ankylosing spondylitis; HLA B*2709; HLA B27; IFN ; Sacroiliitis

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE; HLA B27 ANTIGEN; PREDNISOLONE; RECOMBINANT ALPHA INTERFERON; ALPHA INTERFERON; HLA B ANTIGEN; IMMUNOLOGIC FACTOR;

ADULT; APHERESIS; ARTHRITIS; ARTICLE; ASTHENIA; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; FUNCTIONAL DISEASE; HAND EDEMA; HAND RADIOGRAPHY; HEPATOSPLENOMEGALY; HLA TYPING; HUMAN; KNEE ARTHRITIS; LYMPHADENOPATHY; MAINTENANCE THERAPY; MORNING STIFFNESS; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; RECURRENT DISEASE; REMISSION; SACROILIITIS; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS; ANKYLOSING SPONDYLITIS; CHEMICALLY INDUCED DISORDER; GENETIC PREDISPOSITION; GENETICS; SACROILIAC JOINT;

ADULT; ARTHRITIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-B ANTIGENS; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; SACROILIAC JOINT; SPONDYLITIS, ANKYLOSING; THROMBOCYTHEMIA, ESSENTIAL;

EID: 59149097091     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. KHAN MA, BALL EJ: Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002; 16: 675-90.
2. MATHIEU A, SORRENTINO R: HLA-B*2709 and Spondyloarthropathies. Arthritis Rheum 2003; 48: 866-7.
3. CAULI A, VACCA A, MAMELI A et al.: A Sardinian patient with ankylosing spondylitis and HLA-B2709 co-occurring with HLA-B*1403. Arthritis Rheum 2007; 56: 2807-9.
4. OLIVIERI I, D'ANGELO S, SCARANO E, SANTOSPIRITO V, PADULA A: The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum 2007; 56: 2805-7.
5. TAUROG JD: The mysIery of HLA-B27: if it isn't one thing, it's another. Arthritis Rheum 2007; 56: 2478-81.
6. WATANABE U, HASHIMOTO E, HISAMITSU T, OBATA H, HAYASHI N: The risk factor for development of thyroid disease during interferon-a therapy for chronic hepatitis C. Am J Gastroenterol 1994; 89: 399-403.
7. LEVESQUE MC, WARD FE, JEFFERY DR, WEINBERG JB: Interferon-beta 1A-induced polyarthritis in a patient with the HLA-DRB1 0404 allele. Arthritis Rheum 1999; 42: 569-73.
8. RUSSO R, TENEMBAUM S, MORENO MJ, BATTAGLIOTTI C: Interferon-beta1a-induced juvenile chronic arteritis in a genetically pre-disposed young patient with multiple sclerosis: Comment on the case report by Levesque et al. Arthritis Rheum 2000; 43: 1190.
9. LOMBARDINI F, TAGLIONE E, RIENTE L, PASERO G: Psoriatic arthritis with spinal involvement in a patient receiving alpha-interferon for chronic hepatitis C. Scand J Rheumatol 1997; 26: 58-63.
10. ZHAO L, GRANFORS K, YU DTY: Analyses with a promoter reporter construct and its mutant showed that the response of the HLA-B27 gene to cytokines are both cytokine-specific and time dependent. Arthritis Rheum 2007; 56 (Suppl.): 569.
11. FIORILLO MT, CAULI A, CARCASSI C et al.: Two distintive HLA haplotypes harbor the B27 alleles negatively or positively associated with Ankylosing Spondylitis in Sardinia: Implications for disease pathogenesis. Arthritis Rheum 2003; 48: 1385-9.
12. CASCINO I, PALADINI F, BELFIORE F et al.: Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Arthritis Rheum 2007; 56: 2640-51.
13. KERLAN-CANDON S, LOUIS-PLENCE P, WIEDEMANN A et al.: Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low affinity peptides. Arthritis Rheum 2001; 44: 1281-92.
14. TAUROG JD, MAIKA SD, SIMMONS WA, BREBAN M, HAMMER RE: Susceptibility to inflammatory disease in HLA-B27 trangenic rat lines correlates with the level of B27 expression. J Immunol 1993; 150: 4168-78
15. CAULI A, DESSOLE G, FIORILLO MT et al.: Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27 subjects: A possible further susceptibility factor for the development of disease. Rheumatology 2002; 41: 1375-9.
16. LERISLAO M, SKYLV G, KOUSA M et al.: Follow-up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982; 25: 249-59.